These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12594823)

  • 1. CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls.
    Vineis P; Veglia F; Benhamou S; Butkiewicz D; Cascorbi I; Clapper ML; Dolzan V; Haugen A; Hirvonen A; Ingelman-Sundberg M; Kihara M; Kiyohara C; Kremers P; Le Marchand L; Ohshima S; Pastorelli R; Rannug A; Romkes M; Schoket B; Shields P; Strange RC; Stucker I; Sugimura H; Garte S; Gaspari L; Taioli E
    Int J Cancer; 2003 May; 104(5):650-7. PubMed ID: 12594823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility.
    Xu X; Kelsey KT; Wiencke JK; Wain JC; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):687-92. PubMed ID: 8877059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP1A1 MspI polymorphisms and lung cancer risk: an updated meta-analysis involving 20,209 subjects.
    Ji YN; Wang Q; Lin XQ; Suo LJ
    Cytokine; 2012 Aug; 59(2):324-34. PubMed ID: 22579698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States).
    Le Marchand L; Guo C; Benhamou S; Bouchardy C; Cascorbi I; Clapper ML; Garte S; Haugen A; Ingelman-Sundberg M; Kihara M; Rannug A; Ryberg D; Stücker I; Sugimura H; Taioli E
    Cancer Causes Control; 2003 May; 14(4):339-46. PubMed ID: 12846365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi population.
    Islam MS; Ahmed MU; Sayeed MS; Maruf AA; Mostofa AG; Hussain SM; Kabir Y; Daly AK; Hasnat A
    Clin Chim Acta; 2013 Feb; 416():11-9. PubMed ID: 23178447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
    Zhan P; Wang Q; Qian Q; Wei SZ; Yu LK
    J Exp Clin Cancer Res; 2011 Oct; 30(1):99. PubMed ID: 22014025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.
    Ishibe N; Hankinson SE; Colditz GA; Spiegelman D; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
    Cancer Res; 1998 Feb; 58(4):667-71. PubMed ID: 9485019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP1A1 gene polymorphisms and smoking status as modifier factors for lung cancer risk.
    Hussein AG; Pasha HF; El-Shahat HM; Gad DM; Toam MM
    Gene; 2014 May; 541(1):26-30. PubMed ID: 24613751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies.
    Chen Z; Li Z; Niu X; Ye X; Yu Y; Lu S; Chen Z
    Mutagenesis; 2011 May; 26(3):437-46. PubMed ID: 21402622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility.
    Yang M; Choi Y; Hwangbo B; Lee JS
    Lung Cancer; 2007 Aug; 57(2):135-42. PubMed ID: 17428572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic polymorphisms of CYP1A1 and susceptibility of lung cancer].
    Hu Y; Zhang Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Feb; 16(1):26-8. PubMed ID: 9949237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic polymorphism of cytochrome P4501A1 and susceptibility to laryngeal carcinoma].
    Lei D; Pan X; Guo C; Luan X; Xu F; Zhang L; Liu D
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Oct; 37(5):373-6. PubMed ID: 12772461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer.
    Tan C; Xu HY; Zhang CY; Zhang H; Chen CM; Zhang WM; Sun XY; Jin YT
    Arch Med Res; 2011 Nov; 42(8):669-76. PubMed ID: 22154617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study.
    Raimondi S; Boffetta P; Anttila S; Bröckmoller J; Butkiewicz D; Cascorbi I; Clapper ML; Dragani TA; Garte S; Gsur A; Haidinger G; Hirvonen A; Ingelman-Sundberg M; Kalina I; Lan Q; Leoni VP; Le Marchand L; London SJ; Neri M; Povey AC; Rannug A; Reszka E; Ryberg D; Risch A; Romkes M; Ruano-Ravina A; Schoket B; Spinola M; Sugimura H; Wu X; Taioli E
    Mutat Res; 2005 Dec; 592(1-2):45-57. PubMed ID: 16009381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk.
    Moysich KB; Shields PG; Freudenheim JL; Schisterman EF; Vena JE; Kostyniak P; Greizerstein H; Marshall JR; Graham S; Ambrosone CB
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):41-4. PubMed ID: 9950238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk.
    Gsur A; Haidinger G; Hollaus P; Herbacek I; Madersbacher S; Trieb K; Pridun N; Mohn-Staudner A; Vetter N; Vutuc C; Micksche M
    Anticancer Res; 2001; 21(3C):2237-42. PubMed ID: 11501853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
    Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
    Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population.
    Hirvonen A; Husgafvel-Pursiainen K; Karjalainen A; Anttila S; Vainio H
    Cancer Epidemiol Biomarkers Prev; 1992; 1(6):485-9. PubMed ID: 1284589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.
    Alexandrie AK; Nyberg F; Warholm M; Rannug A
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):908-14. PubMed ID: 15184245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
    Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.